Design, Setting, and Patients Positron emission tomography (PET) studies of [18F]fluorodeoxyglucose in 146 patients undergoing evaluation for dementia with at least 2 years' follow-up for disease progression at the University of California, Los Angeles, from 1991 to 2000, and PET studies in 138 patients undergoing evaluation for dementia at an international consortium of facilities, with histopathological diagnoses an average of 2.9 years later, conducted from 1984 to 2000.
S FDG-PET so pregledali 146 bolnikov, ki so jih na University of California v Los Angelesu obravnavali zaradi demence in so jih sledili če vsaj 2 leti po preiskavi, ter 138 bolnikov, ki so jih obravnavali v drugih sodelujočih ustanovah in so bile zanje po povprečno 2,9 letih na voljo histopatoločke diagnoze.